Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bard Receives Clearance for Improved Biliary Stent.


Business, Health & Medical Editors

MURRAY HILL, N.J.--(BW HealthWire)--Jan. 11, 2000

C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE-BCR) announced today it has received U.S. FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 510(k) concurrence to market the Memotherm FLEXX biliary stent biliary stent Biliary endoprosthesis Surgery A tube inserted into a stenosed or obstructed narrowed or blocked bile duct to improve bile flow  for treating malignant biliary obstructions. The Memotherm FLEXX biliary stent will be marketed through Bard's Peripheral Technologies division and will be available immediately.

The unique, flexible design of both the Memotherm FLEXX biliary stent and associated delivery system enable the device to negotiate tortuous anatomy and allows the stent to conform to acute bends in the biliary duct. The Memotherm FLEXX biliary stent also provides the radial strength necessary to maintain patency pa·ten·cy
n.
The state or quality of being open, expanded, or unblocked.



patency

the condition of being open.
. It is available in a range of stent diameters from 6-12mm and in lengths from 20-120mm.

"The Memotherm FLEXX biliary stent and delivery system is the newest member of Bard's growing family of stents, and we believe that it represents a significant step forward in technology," stated William H. Longfield, chairman and chief executive officer. "In addition to setting a new level of flexibility and strength, the Memotherm FLEXX system offers the clinician a broad product selection to combat a wide range of malignant obstructions," Longfield concluded.

C. R. Bard, Inc., headquartered in Murray Hill, New Jersey
For other places with the same name, see Murray Hill.
Murray Hill is an unincorporated area within portions of both Berkeley Heights and New Providence, located in Union County in north-central New Jersey.
, is a leading multinational developer, manufacturer and marketer of health care products.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 11, 2000
Words:217
Previous Article:uReach.com Hires Former Sarnoff Corporation Executive David J. Warnock as CFO.
Next Article:Greg Manning Auctions and Butterfields Auctioneers Co-Sponsor Multimillion Dollar Auction of Kiss Rock Band Costumes, Instruments and Memorabilia.



Related Articles
Bard receives marketing clearance for Memotherm Stent.
Bard Receives FDA Clearance for Biliary Stent.
Bard Receives FDA Clearance for Endoscopic Biliary Stent.
Extrahepatic bile duct stricture and elevated CA 19-9: malignant or benign? (Case Report).
Jaundice secondary to isolated porta hepatis metastasis in colorectal cancer: case report and review of the literature.
Nostril stenosis secondary to a laser burn injury: correction with a composite graft.
Endovascular treatment of intrahepatic inferior vena cava obstruction from malignant hepatocellular tumor thrombus utilizing Luminexx self-expanding...
Advances in the endoscopic management of patients with pancreatic and biliary malignancies.
Clear the way: stenting opens jammed arteries in the brain.
FIRST HEART ATTACK PATIENT ENROLLED IN RAPID MI-ICE STUDY.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles